Are Analysts Too Bullish On Dermata Therapeutics Inc (DRMA)

money audit

Dermata Therapeutics Inc (NASDAQ:DRMA) currently has a daily average trading volume of 2.52M but it saw 1778171 shares traded in last market. With a market cap of 2.39M USD, the company’s current market price of $1.58 came rising about 18.80 while comparing to the previous closing price of $1.33. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.62 and as low as $1.22. In the recent trading on the day, stock has struck highest price mark of $1.31 while lowest mark touched by it was $1.59.

Taking a look at 20-day trading activity of Dermata Therapeutics Inc (DRMA) gives us an average price of $1.4653, while its current price level is -89.20% below from 52-week high level whereas it is 29.51% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.7179 while that of 200 days or SMA-200 reads an average of $4.1507. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.68% during that period while stretching the period over a month that decreases to 10.38%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.04 which implies that the stock is in neutral territory.

Over the week, DRMA’s stock price is moving 17.91% up while it is -29.78% when we observe its performance for the past one month. Year-to-date it is -82.73% down and over the past year, the stock is showing a downside performance of -85.99%.

Currently, Dermata Therapeutics Inc’s total number of outstanding shares is 1.51M. Company’s return on investment (ROI) stands at -295.85% and return on equity (ROE) at -173.01%. Stock’s beta reads 0.77. Stock has a price to book (P/B) ratio of 0.33. Its return on asset (ROA) is -140.74% on average.